Life Spine issued the following announcement on August 5.
Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced that it has received clearance from the U.S. Food & Drug Administration (FDA) to market the PLATEAU-A Ti Anterior Lumbar Spacer System.
“With the increased usage of anterior column reconstruction, PLATEAU-A Ti fills an important portfolio gap. Joining our recently launched DYNA-LINK® Titanium Stand-Alone ALIF Spacer System and SENTRY® ALIF Plating System, this clearance expands our robust ALIF portfolio,” said Rich Mueller, Chief Operating Officer for Life Spine. “Continuing our success with previous interbody technologies, PLATEAU-A Ti provides surgeons with a titanium implant available in a variety of heights, widths, and lordotic options.”
PLATEAU-A Ti Anterior Lumbar Spacer System is a comprehensive system that can be used for anterior fusion procedures. Multiple footprint sizes are available in various heights to accommodate individual patient anatomies and pathologies to promote fusion.
Key Features and Benefits:
- Large, open graft windows for maximum visibility and bone graft containment
- Osseo-Loc™ Surface Treatment Technology
- Chamfered leading edge to ease implant insertion
Life Spine is dedicated to improving the quality of life for spinal patients by increasing procedural efficiency and efficacy through innovative design, uncompromising quality standards, and the most technologically advanced manufacturing platforms. Life Spine, which is privately held, is based in Huntley, Illinois. For more information, please visit: http://www.lifespine.com and/or https://www.micro-invasive.com.
Original source can be found here.
